South Wales, Dec. 26 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "AGILERA" on Dec. 5. The details about the trademark application no. UK00004306052 published in the journal no. 2025/051 (Dec. 19).
With Edwin Coe LLP as representative, Agilera Pharma AS filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Radiopharmaceutical and radioisotope preparations for clinical, medical, diagnostic and therapeutic use.
Class 35 : Regulatory submission management services, namely, assisting others in preparing and filing applications for radiopharmaceuticals with governmental regulatory bodies; distributorship services in the field of radiopharmaceuticals; distributorship services featuring pharmaceuticals, radiopharmaceuticals, and nuclear medicine products; business management and logistics management in the field of radiopharmaceuticals; supply chain management for pharmaceutical and radiopharmaceutical products; business administration and consulting services for radiopharmaceutical and radiopharmacy operations.
Class 39 : Supply chain and logistics services, namely, transportation, delivery, distribution, and storage of radiopharmaceuticals and radioisotopes; consultation and coordination services relating to the transport and storage of radiopharmaceuticals and radioisotopes.
Class 40 : Manufacturing services in the field of pharmaceuticals and radiopharmaceuticals; isotope production for medical, research, and commercial use; contract development and manufacturing services (CDMO) in the field of pharmaceuticals and radiopharmaceuticals; Custom manufacture of pharmaceuticals; Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials.
Class 42 : Scientific and technological services and research in the field of radiochemistry, radiopharmaceuticals, and nuclear medicine; laboratory testing, quality control, and validation services for radiopharmaceuticals; process development, optimization, and scale-up services; technological consultancy relating to radiopharmaceutical production and regulatory compliance; design and development of computer software for radiopharmacy workflow management, data analysis, and quality assurance; Pharmaceutical drug development services; Laboratory services for the production of radiopharmaceuticals in the nature of research and development of new products and testing of pharmaceuticals; Quality control for others.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004306052
Disclaimer: Curated by HT Syndication.
